Illness	Number of cases
Hyperplasia of prostate (N40)	289
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	268
Malignant neoplasm of prostate (C61)	205
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	157
Calculus of kidney and ureter - Calculus of kidney (N20.0)	153
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	124
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	104
Cystitis (N30.2)	89
Unspecified haematuria (R31)	67
Malignant neoplasm of kidney except renal pelvis (C64)	64

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.075
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	1.014
Examination of the urethra and the urinary bladder by endoscopy (1-661)	656
Insertion, exchange or removal of a ureteral stent (8-137.00)	616
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	491
X-rays of the urinary bladder with contrast medium (3-13f)	466
Examination of the ureter by endoscopy (1-665)	360
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.8)	295
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	282
Insertion, exchange or removal of a ureteral stent (8-137.10)	281

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
43	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
40	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
37	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre phase III/IV studies
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB03	Physical therapist / physiotherapist (m/f)
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)